Startseite>>Lipids>> Glycerolipids>>1-Stearoyl-rac-glycerol

1-Stearoyl-rac-glycerol (Synonyms: 18:0-MG, MG(18:0/0:0/0:0), 1-Monostearin, NSC 3875)

Katalog-Nr.GC40176

1-Stearoyl-rac-glycerol is a monoacylglycerol that contains stearic acid at the sn-1 position.

Products are for research use only. Not for human use. We do not sell to patients.

1-Stearoyl-rac-glycerol Chemische Struktur

Cas No.: 123-94-4

Größe Preis Lagerbestand Menge
100mg
79,00 $
Auf Lager
250mg
166,00 $
Auf Lager
500mg
310,00 $
Auf Lager

Tel:(909) 407-4943 Email: sales@glpbio.com

Kundenbewertungen

Basiert auf Kundenrezensionen.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

1-Stearoyl-rac-glycerol is a monoacylglycerol that contains stearic acid at the sn-1 position. 1-Stearoyl-rac-glycerol levels are decreased in tumor tissue in a mouse model of azoxymethane-induced colorectal carcinogenesis. Levels of 1-stearoyl-rac-glycerol are decreased in lung tissue from patients with adenocarcinoma, but are increased in the serum of patients with Buruli ulcer and in the cerebrospinal fluid of patients with the inflammatory demyelinating diseases multiple sclerosis (MS), neuromyelitis optica spectrum disorder (NMOSD), and idiopathic transverse myelitis (ITM). 1-Stearoyl-rac-glycerol has been used in the composition of transfersomes for transdermal delivery of doxorubicin in rats, leading to doxorubicin accumulation in lymph nodes, spleen, and heart.

Bewertungen

Review for 1-Stearoyl-rac-glycerol

Average Rating: 5 ★★★★★ (Based on Reviews and 22 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for 1-Stearoyl-rac-glycerol

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.